Breaking News, Collaborations & Alliances

CordenPharma & Moderna Extend Manufacturing Agreement

For the supply of lipid excipients to be used in Moderna's coronavirus vaccine

By: Contract Pharma

Contract Pharma Staff

CordenPharma, a full-service contract development and manufacturing organization (CDMO) for the supply of APIs, drug products and pharmaceutical packaging, has signed an amendment to its existing manufacturing agreement with Moderna, a clinical stage biotech developing messenger RNA (mRNA) therapeutics and vaccines. The extension enables CordenPharma to manufacture large-scale volumes of Moderna’s lipid excipients to be used in the manufacture of Moderna’s vaccine candidate (mRNA-127...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters